Economic and clinical burden of comorbidities among patients with acromegaly.

Objective: Acromegaly is a rare, pituitary hormonal disorder that requires improved awareness worldwide. The objective of this analysis was to quantify the clinical and economic burden of comorbidities for patients with acromegaly and examine the influence of biochemical control on these outcomes.

Study Design: Markov cohort decision analytic model consisting of two states, including alive (with and without comorbidity) and dead.

Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly.

Objective: Acromegaly is associated with increased morbidity and mortality. Limited data are available on these patients' utilization and costs of health care. This study assessed the impact of acromegaly on employees' health benefit (direct and indirect) costs and absenteeism.

Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care.

Background: Limited information is available on the utilization and healthcare costs among patients with acromegaly. The purpose of this study was to assess the impact of acromegaly on healthcare utilization and costs by locations of care (LoC).

Methods: Patients with acromegaly and controls were identified from an analysis of drug and medical claims filed from January 2010 to April 2019 from a US employer database.